Phase II study of clinical benefit of oral tegafur (T), levofolinic acid (L) and megestrol acetate (M) in patients with symptomatic hormone-refractory metastatic carcinoma of the prostate (HRMCP) final results

2004 ◽  
Vol 22 (14_suppl) ◽  
pp. 4677-4677
Author(s):  
E. Batiste-Alentorn ◽  
E. Gallardo ◽  
A. Balil ◽  
F. Gili ◽  
J. Carles ◽  
...  
Keyword(s):  
Phase Ii ◽  
Clinical Benefit ◽  
Phase Ii Study ◽  
Metastatic Carcinoma ◽  
Megestrol Acetate ◽  
Carcinoma Of The Prostate ◽  
Hormone Refractory

Phase II Study of Megestrol Acetate for Metastatic Carcinoma of the Prostate

1987 ◽  
Vol 59 (5) ◽  
pp. 443-446 ◽  
Author(s):  
CATHERINE CROMBIE ◽  
D. RAGHAVAN ◽  
J. PAGE ◽  
R. WOODS ◽  
D. DALLEY ◽  
...  
Keyword(s):  
Phase Ii ◽  
Phase Ii Study ◽  
Metastatic Carcinoma ◽  
Megestrol Acetate ◽  
Carcinoma Of The Prostate

Megestrol acetate: Phase II study of a single daily administration in advanced breast cancer

1990 ◽  
Vol 17 (1) ◽  
pp. 51-54 ◽  
Author(s):  
Paolo Pronzato ◽  
Fulvio Brema ◽  
Domenico Amoroso ◽  
Gianfilippo Bertelli ◽  
Pier Franco Conte ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Advanced Breast Cancer ◽  
Phase Ii ◽  
Phase Ii Study ◽  
Advanced Breast ◽  
Megestrol Acetate ◽  
Daily Administration

scholarly journals RARE-24. OBJECTIVE RESPONSE AND CLINICAL BENEFIT IN RECURRENT EPENDYMOMA IN ADULTS: FINAL REPORT OF CERN 08-02: A PHASE II STUDY OF DOSE-DENSE TEMOZOLOMIDE AND LAPATINIB

2018 ◽  
Vol 20 (suppl_6) ◽  
pp. vi241-vi241 ◽  
Author(s):  
Terri Armstrong ◽  
Ying Yuan ◽  
Jimin Wu ◽  
Tito Mendoza ◽  
Elizabeth Vera ◽  
...  
Keyword(s):  
Phase Ii ◽  
Clinical Benefit ◽  
Phase Ii Study ◽  
Objective Response ◽  
Final Report ◽  
Recurrent Ependymoma ◽  
Dose Dense

Docetaxel, Vinorelbine, and Zoledronic Acid as First-Line Treatment in Patients with Hormone Refractory Prostate Cancer: A Phase II Study

2007 ◽  
Vol 52 (4) ◽  
pp. 1020-1027 ◽  
Author(s):  
Giuseppe Di Lorenzo ◽  
Riccardo Autorino ◽  
Sisto Perdonà ◽  
Michele De Laurentiis ◽  
Massimo D'Armiento ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Zoledronic Acid ◽  
Phase Ii ◽  
Phase Ii Study ◽  
Hormone Refractory Prostate Cancer ◽  
Line Treatment ◽  
First Line ◽  
Hormone Refractory ◽  
First Line Treatment

scholarly journals A phase II study of continuous infusion 5-fluorouracil in advanced hormone refractory prostate cancer. An illinois cancer center study

Cancer ◽  
1993 ◽  
Vol 72 (6) ◽  
pp. 1965-1968 ◽  
Author(s):  
Timothy M. Kuzel ◽  
Martin S. Tallman ◽  
Daniel Shevrin ◽  
Edward Braud ◽  
Lary Kilton ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Continuous Infusion ◽  
Phase Ii ◽  
Phase Ii Study ◽  
Cancer Center ◽  
Hormone Refractory Prostate Cancer ◽  
Hormone Refractory ◽  
Center Study
Sign in / Sign up

Export Citation Format

Share Document